Catalyst Wire Dossier Catalyst Wire Dossier

Flucelvax Tetra

influenza vaccine, quadrivalent (cell culture-based) · Seqirus Netherlands B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flucelvax Tetra, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: EMA Withdrawn: Flucelvax Tetra (A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022, CVR-167) A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type) B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type)) — Seqirus Netherlands B.V.

See pricing